Title: Quality Improvement In Stroke Care For Primary Stroke Center Certification at St. Francis Health Center
1- Quality Improvement In Stroke Care For Primary
Stroke Center Certification at St. Francis Health
Center - Washburn University
- Masters Project by
- Jill Collins, RN BSN
- December 2012
2What Is Primary Stroke Center Certification?
- It is a program developed in 2003 by The Joint
Commission in collaboration with The American
Heart Association/American Stroke Association - Initiated in an effort to raise the bar for
hospital stroke care - Recognizes centers who follow best practices for
stroke care
3Why Become Primary Stroke Center Certified?
- To provide our patients with the highest quality
stroke care in order to eliminate or
reduce disability and return them as near as
possible to their previous functional capacity. - To ensure the highest level of reimbursement for
the quality care that we give
4Why Address Stroke Care?Stroke Statistics
- 3rd leading cause of death in the U.S. annually
- Approximately 795,000 people are diagnosed with
a - stroke yearly
- 140,000 stroke related deaths occur annually
- Many health conditions which are risk factors
for stroke - are on the rise in the U.S. including obesity,
diabetes - and hypertension
- In 2010, approximately 73.7 billion was spent
on - stroke-related medical costs and disability
5What Are the Elements of Primary Stroke Center
Certification?
- Use of a standardized method of delivering care
- Support patient self-management activities
- Tailor treatment and interventions to individual
needs - Promote flow of patient information across
settings and providers while maintaining HIPPA - Analyze and use standardized performance measure
data to continually improve treatment plans - Demonstrate application of and compliance with
clinical practice guidelines as established by
American Heart Association/American Stroke
Association
6Quality and Performance Improvement
- Very important aspect of providing the best
quality of care - Requirement for Primary Stroke Center
Certification - Involves continual data extraction from charts,
input into database, analysis of data,
recognition of areas needing improvement,
implementing a plan of action and re-evaluation.
7Get With the Guidelines-Stroke Registry
(GWTG-Stroke)
- National database registry for entry of
performance data on specified outcomes which
include items such as those found in the stroke
core measure set and recommended best care
practices from the American Heart
Association/American Stroke Association - Also provides information such as demographics,
admitting diagnoses, discharge diagnoses,
treating providers and pre-existing risk factors
of patients - Allows hospitals to not only monitor their own
performance internally but also allows for
comparison with hospitals of similar size and
comparison to hospitals within the state, region
and nation - Was recently initiated at St. Francis Health
Center and currently has data on over 200
patients as part of my masters project
8St. Francis Health Center Performance Data from
GWTG-Stroke
- The following slides will review data collected
from the registry in regard to performance
at St. Francis. This shows some of the
demographics and well as select areas of
performance. Each performance area will have
prior explanation as to why it was chosen to be
included in this presentation. - For purposes of data graphs Baseline data is
obtained from 30 random stroke charts from 1/1/11
to 6/30/11, 2011 data is from all stroke charts
from 7/1/11 to 12/31/11, current data is from
all stroke charts from 1/1/12 to 8/31/12 and all
hospitals is data taken from participating
hospitals across the nation from 1/1/12 to
8/31/12.
9What Does Our Stroke Patient Population Look Like?
10What Does Our Stroke Patient Population Look Like?
11What Does Our Stroke Patient Population Look Like?
12What Kind Of Medical Problems Do Our Stroke
Patients Have?
13What Types of Strokes Do Our Patients Have?
14What are Core Measure Sets?
- A core set of recommended best practices to
follow in regard to a given diagnosis - A method for The Joint Commission and Medicare to
identify and prioritize unresolved issues
regarding healthcare performance - Play an important role in establishing and
maintaining Joint accreditation and receiving
Medicare reimbursement - Current core measure sets are established for
stroke, MI, pneumonia, CHF and surgical infection
prophylaxis - Goal to be above 90 in all areas
15Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
- 1. Venous thromboembolism prophylaxis (VTE).
Documentation should be made of either having an
ambulatory status or receiving VTE prophylaxis by
the end of hospital day 2. This can be
accomplished by administering subcutaneous
unfractionated heparin, low-molecular weight
heparins or heparinoids in patients with acute
ischemic strokes. If there are contraindications
to anticoagulants or the patient has had a
hemorrhagic stroke, intermittent pneumatic
compression devices or elastic stockings are
recommended. Rationale patients who
experience a stroke in which a lower extremity is
paralyzed or paretic or who are otherwise
non-ambulatory have increased risk of developing
VTE or pulmonary embolism (PE). PEs account for
10 of deaths after stroke. VTE prophylaxis has
been shown to lower the risk of VTE and PE by
70-80 in clinical trials (Outcome Sciences
Inc., 2011).
16St. Francis Data on VTE Prophylaxis
17Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
- 2. Antithrombotics prescribed at discharge if
the patient was diagnosed with non-cardioembolic
ischemic stroke or transient ischemic attack.
Antiplatelets rather than oral anticoagulation
are recommended to reduce the risk of recurrent
stroke and other cardiovascular events. Aspirin
(50-325mg/day), Aggrenox (25/200 mg BID) or
clopidogrel (75 mg/day) are all recommended
therapies. Rationale substantial evidence has
been accumulated from many large clinical trials
which support the effectiveness of antithrombotic
agents in reducing stroke mortality,
stroke-related morbidity and recurrence rates.
If the stroke is due to a cardioembolic source
(i.e. atrial fibrillation or mechanical heart
valve), warfarin is the preferred choice unless
contraindicated (Outcome Sciences Inc., 2011).
18St. Francis Data on Antithrombotics at Discharge
19Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
- 3. Anticoagulation prescribed for atrial
fib/atrial flutter. Patients with an ischemic
stroke or transient ischemic attack who also have
atrial fibrillation and/or atrial flutter should
be discharged home on anticoagulation. Warfarin
is the preferred treatment with dosages given to
achieve an international normalized ratio (INR)
of 2.0 to 3.0. If patients are unable to take
anticoagulants, aspirin alone is recommended.
Rationale non-valvular atrial fibrillation is a
common arrhythmia and has been identified as a
substantial risk factor for stroke. In several
clinical trials done on patients with atrial
fibrillation, the use of warfarin has been shown
to decrease the relative risk of thromboembolic
stroke by 68.
20St. Francis Data on Anticoagulants for Atrial
Fib/Flutter
21Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
- 4. IV tPA arrive by 2 hour, treat by 3 hour.
Patients with acute ischemic stroke who arrive
within 2 hours of the time they were last known
to be well should have IV tPA initiated within 3
hours of the time last known to be well. These
patients must meet inclusion criteria as
established by the American Heart Association.
Rationale several clinical trials show
favorable outcomes (defined as complete or nearly
complete neurological recovery 3 months after a
stroke) were achieved in 31-50 of patients
treated with IV tPA within 3 hours of onset of
symptoms . The major society practice guidelines
developed in the US all recommend the use of IV
tPA for eligible patients (Outcome Sciences Inc.,
2011).
22St. Francis Data on IV tPA Arrive By 2 Hours,
Treat by 3 Hours
23Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
-
- 5. Early antithrombotics. Patients with
ischemic stroke or transient ischemic attack
should receive antithrombotic therapy by the end
of hospital day 2. The recommended agents are
the same as listed above in the antithrombotics
at discharge section for the same rationale.
Data suggests that antithrombotic therapy should
be initiated within 48 hours of symptoms onset in
order to reduce morbidity and mortality (Core
Measure Sets Stroke, 2011).
24St. Francis Data on Early Antithrombotics
25Core Measure Performance at St. Francis From
GWTG-Stroke Database
- 6. LDL 100 or not documented discharged on
statin. Patients with ischemic stroke or
transient ischemic attack with an LDL greater
than or equal to 100, not measured or already on
a cholesterol reducing agent prior to admission
should be discharged on a statin medication
unless there is a documented contraindication
such as allergy. Rationale Elevated serum
lipid levels are a well-documented risk for
coronary artery disease and reflects an
organ-specific manifestation of atherosclerosis
which is a disease process that can affect the
heart as well as major and minor branches of the
arterial tree. Symptomatic carotid artery
disease is one of the recognized coronary disease
risk equivalents. The Stoke Prevention by
Aggressive Reduction in Cholesterol Levels
(SPARCL) study examined the effects of statins to
lower LDL cholesterol in patients with stroke or
transient ischemic attack of atherosclerotic
origin who had no other reason for taking lipid
lowering therapy and had a fasting LDL of greater
than or equal to 100 mg/dL. This trial
convincingly demonstrated that intensive lipid
lowering therapy using statin medication was
associated with a dramatic reduction in the rate
of recurrent ischemic stroke and major coronary
events (Core Measure Sets Stroke, 2011).
26St. Francis Data on LDL Results and Statin
Prescription
27Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
- 7. Stroke Education. Patients with stroke or
transient ischemic attack or their caregivers
should be given on education and/or educational
materials during the hospital stay addressing all
of the following personal risk factors, warning
signs for stroke, activation of emergency medical
system, need for follow-up after discharge and
medications prescribed. There should be a
specific team member identified to provide
information to the patient and caregiver.
Rationale many examples of how patient
education programs for specific chronic
conditions have increased healthy behaviors,
improved health status and/or decreased health
costs of their participants. Some clinical
trials show measurable benefits in patient and
caregiver outcomes with the application of
education and support strategies (Outcome
Sciences Inc., 2011).
28St. Francis Data on Stroke Education
29Core Measure Performance at St. Francis From
GWTG-Stroke Database
-
- 8. Rehabilitation considered. All patients
diagnosed with stroke should be assessed for
rehabilitation services. When the patient is
medically stable, a consult should be placed for
rehabilitation services to assess patient
impairments as well as activity and participation
deficiencies to establish the patients
rehabilitation needs and goals. It is strongly
recommended that patients with mild to moderate
disability in need of rehab services have access
to a setting with coordinated and organized
rehabilitation care team which is experienced in
providing stroke services. Rationale of the
795,000 patients who experience a new or
recurrent stroke annually, about 2/3 survive and
require rehab. A large body of evidence
indicates better clinical outcomes when these
patients are treated in a setting which provides
coordinated, multidisciplinary stroke-related
evaluation and services. These treatments can
enhance the recovery process and minimize
functional disability (Outcome Sciences Inc.,
2011).
30St. Francis Data on Rehab Assessment
31The Golden Hour of Stroke Care
- The benefit of IV thrombolytic therapy in
acute brain ischemia is very much time dependent.
Therapeutic yield is maximal in the first
minutes after the onset of symptoms and decreases
during the next 4.5 hours. In a typical ischemic
stroke, for each minute reperfusion is delayed, 2
million nerve cells die. In every 100 patients
treated with IV thrombolytic therapy, for every
10 minute delay in the start of lytic infusion
within the 1 to 3 hour treatment window, 1 fewer
patient has an improved disability outcome.
Because of the critical importance in rapid
treatment, national recommendations for hospitals
that accept acute stroke patients in their
Emergency Departments are to complete the
clinical and imaging evaluation of the patient
and initiate lytic therapy within 1 hour (the
golden hour) of patient arrival. The Joint
Commission target for primary stroke centers is
to achieve a door-to-needle time (arrival to
start of IV lytic therapy) of within 60 minutes
in 80 or more of patients (Saver, et al.,
2010). In order for patients to have IV lytics
started, a certain sequence of events has to
occur including evaluation by the MD, initiation
of labwork, NIH stroke scale completed, CT scan
of the brain done within 25 minutes and
interpreted by a radiologist and review of
eligibility for tPA. This also would mean that
the goal for NIH stroke scale and door to CT lt 25
minutes be 80 or more.
32St. Francis Golden Hour of Stroke Care Data
33St. Francis Golden Hour of Stroke Care Data
34St. Francis Golden Hour of Stroke Care Data
35Dysphagia Screening
-
- Dysphagia screen one of the common
presentations for stroke patients is difficulty
talking and swallowing. The origin of these
manifestations also put the patient at risk for
aspiration. Because of this, a bedside dysphagia
screen should be performed by a nurse and if the
patient does not pass this, a formal swallow
study should be done by speech therapy before the
patient has anything by mouth including medication
36St. Francis Data for Dysphagia Screening
37 Smoking Cessation Education
-
- Smoking cessation education. Smoking is a
common and modifiable risk factor for stroke.
Education and assistance are key to eliminating
this risk factor.
38St. Francis Data on Smoking Cessation Education
39What Areas Do We Need to Work On?
-
- The following are core measure items that fall
below the 90 goal for purposes of the
GWTG-Stroke data - VTE Prophylaxis
- Discharge on anticoags if patient has
afib/flutter - Stroke Education
- IV tPA in 3 hours if arrived by hour 2
40What Areas Do We Need to Work On?
-
- The following items currently fall below the
suggested 80 benchmark as per The Joint
Commission in regard to the Golden Hour of
stroke care - NIHSS initially completed
- Door to Needle less than 60 minutes
- Door to CT lt 25 minutes
- Final item for improvement
- Dysphagia Screening
41Recommendations
- Return Stroke Coordinator position to an
associate who solely works on improving stroke
care and possibly other quality improvement
projects. This person can then be responsible
for the following which would likely improve
scores and quality of care - Consistent and continual education throughout the
facility on stroke care requirements and
recommendations - Monitoring core measures as well as GWTG
recommendations - Following up with patient care teams to review
care given and make suggestions for improvement.
This would help with accountability - Maintain the GWTG-Stroke database for St.
Francis, analyze findings and implement changes - Work closely with the medical director of the
stroke program to ensure policies, procedures
and order sets are consistent with best-practice
guidelines
42Summary
- In all, St. Francis Health Center really is
doing a great job in providing quality stroke
care. There are just a few items needing
improvement. Most of these items are showing
steady improvement. The items that have the
lowest performance are still quite comparable and
in some cases even better than hospitals
nationwide. With additional and continual
education and monitoring, I think these numbers
would soon all be at goal.
43References
- Core Measure Sets Stroke. (2011, February 4).
Retrieved April 25, 2012, from The Joint
Commission - http//www.jointcommission.org/core_mea
sure_sets.aspx - George, M. G., Tong, X., Yoon, P. W. (2011,
February 25). Morbidity and Mortality Weekly
Report (MMWR). - Retrieved January 15, 2012, from
Centers for Disease Control - http//www.cdc.gov/mmwr/preview/mmwrhtm
l/mm6007a2.htm - Katz, M. J. (2010). Stroke A Comprehensive
In-Depth Review. Retrieved July 3, 2012, from
NursingCEU.com - http//www.nursingceu.com/courses/301/i
ndex_nceu.html - Leifer, D., Bravata, D. M., Connors III, J.,
Hinchey, J. A., Jauch, E. C., Johnston, S. C., et
al. (2011). Metrics for - Measuring Quality of Care in
Comprehensive Stroke Centers Detailed Follow-Up
to a Brain Attack Coalition - Comprehensive Stroke Center
Recommendations A Statement for Healthcare
Professionals From the American - Heart Association. Stroke Journal of
the American Heart Association (online) , 1-29. - Otwell, J. L., Phillippe, H. M., Dixon, K. S.
(2010). Efficacy and Safety of IV Alteplase
Therapy Up to 4.5 Hours After - Acute Ischemic Stroke Onset. American
Journal of Health-System Pharmacists , 1070-1074. - Outcome Sciences Inc. (2011). The Outcome System.
Retrieved July 10th, 2012, from
https//qi.outcome.com